XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Impact of adopting ASC 326, net of tax
Total stockholders' equity attributable to parent
Total stockholders' equity attributable to parent
Impact of adopting ASC 326, net of tax
Common stock
Additional paid-in capital
Retained earnings
Retained earnings
Impact of adopting ASC 326, net of tax
Accumulated other comprehensive income (loss)
Treasury stock
Noncontrolling interest
Beginning balance (in shares) at Dec. 31, 2022         13,466,281            
Beginning balance (in shares) at Dec. 31, 2022                   848,016  
Beginning balance at Dec. 31, 2022 $ 261,391 $ (6,642) $ 261,084 $ (6,642) $ 13,466 $ 157,152 $ 144,911 $ (6,642) $ (37,704) $ (16,741) $ 307
Increase (Decrease) in Stockholders' Equity                      
Net income (loss) 11,220   11,342       11,342       (122)
Other comprehensive (loss) income 6,766   6,766           6,766    
Dividends on common stock (2,146)   (2,146)       (2,146)        
Stock-based compensation 831   831     831          
Stock-based compensation related to equity method investment 69   69     69          
Common stock options exercised (in shares)         4,450            
Common stock options exercised 70   70   $ 4 66          
Restricted stock units issued (in shares)         43,882            
Restricted stock units issued 0   0   $ 44 (44)          
Minimum tax withholding on restricted stock units issued (in shares)         (13,416)            
Minimum tax withholding on restricted stock units issued (243)   (243)   $ (13) (230)          
Ending balance (in shares) at Mar. 31, 2023         13,501,197            
Ending balance (in shares) at Mar. 31, 2023                   848,016  
Ending balance at Mar. 31, 2023 $ 271,316   271,131   $ 13,501 157,844 147,465   (30,938) $ (16,741) 185
Beginning balance (in shares) at Dec. 31, 2023 12,758,383       13,606,399            
Beginning balance (in shares) at Dec. 31, 2023 848,016                 848,016  
Beginning balance at Dec. 31, 2023 $ 289,342   289,384   $ 13,606 160,488 160,862   (28,831) $ (16,741) (42)
Increase (Decrease) in Stockholders' Equity                      
Net income (loss) 4,502   4,482       4,482       20
Other comprehensive (loss) income (1,968)   (1,968)           (1,968)    
Dividends on common stock (2,145)   (2,145)       (2,145)        
Stock-based compensation 780   780     780          
Stock-based compensation related to equity method investment 104   104     104          
Common stock options exercised (in shares)         82,500            
Common stock options exercised $ 1,213   1,213   $ 83 1,130          
Ending balance (in shares) at Mar. 31, 2024 12,840,883       13,688,899            
Ending balance (in shares) at Mar. 31, 2024 848,016                 848,016  
Ending balance at Mar. 31, 2024 $ 291,828   $ 291,850   $ 13,689 $ 162,502 $ 163,199   $ (30,799) $ (16,741) $ (22)